Crossmark

Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer’s disease therapy

Published Online: 2024-01-10

Published Print: 2024-05

Authors

Tarif, Abu Md Mamun

Huhe, Hasi

Ohno, Masuo https://orcid.org/0000-0003-4215-8212
Funding

Funding for this research was provided by:

National Institute on Aging (AG064149)
License Information

Text and Data Mining valid from 2024-01-10

Version of Record valid from 2024-01-10
More Information

Article History

Received: 14 September 2023

Accepted: 29 December 2023

First Online: 10 January 2024

Declarations

:

: The authors declare no competing interests.

Document is current